iCOPE, a multi-level, cluster randomized, 36-month, parallel-group study to assess the efficacy of HIV disclosure intervention in HIV parental disclosure among parents living with HIV in China.
Xiaoming LiShan QiaoYuejiao ZhouPublished in: SAGE open medicine (2020)
The iCOPE study is among the first efforts to develop and evaluate a theory-based and multi-level intervention to promote culturally and developmentally appropriate parental HIV disclosure in China. It has implications for healthcare providers, social workers, and policy makers as it will provide efficacy data on how to enhance appropriate parental HIV disclosure and will shed light on developing a clinical guideline regarding parental HIV disclosure in China and other low- and middle-income countries.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- healthcare
- hiv aids
- hepatitis c virus
- men who have sex with men
- randomized controlled trial
- public health
- mental health
- south africa
- clinical trial
- machine learning
- open label
- deep learning
- artificial intelligence
- phase iii
- health information